SCHEMBL1021792

SCHEMBL1021792

O=C(O)OC1c2ccc(OCCn3ccnc3)cc2CCN1S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 5/20 0.44
CACNA1B Q00975 3/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 2/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP7 P09237 1/20 0.40
MMP9 P14780 1/20 0.40
MMP12 P39900 1/20 0.40
MMP14 P50281 1/20 0.40
MMP15 P51511 1/20 0.40
MMP16 P51512 1/20 0.40
MMP26 Q9NRE1 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1022854 0.92 MMP1 (0.48) TBXAS1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL1021990 0.92 CACNA1B (0.43) TBXAS1CACNA1BALDH1A1KDM4EL3MBTL1
SCHEMBL1021485 0.92 CACNA1B (0.43) TBXAS1CACNA1BALDH1A1KDM4EL3MBTL1
SCHEMBL1021791 0.89 TBXAS1 (0.46) TBXAS1CACNA1BALDH1A1KDM4EL3MBTL1
SCHEMBL3538924 0.85 MMP1 (0.45) TBXAS1CACNA1BALDH1A1L3MBTL1LMNA
SCHEMBL1022410 0.85 MMP1 (0.54) TBXAS1CACNA1BL3MBTL1LMNAMMP1
SCHEMBL1021973 0.85 MMP1 (0.47) TBXAS1ALDH1A1KDM4ELMNAMEN1
SCHEMBL1021841 0.85 ESR1 (0.55) CACNA1BKDM4EESR1ESR2MMP1
SCHEMBL1021032 0.84 MMP1 (0.49) TBXAS1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL1019184 0.84 MMP1 (0.47) ESR1ESR2KMT2AMMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 WO disclosed